Diwali 2025 Bonus Share Picks: 2 Stocks To Watch Before Record Date

All eyes are on corporate actions that might provide a seasonal boost to equities as the auspicious festival of Diwali draws near, bringing optimism for wealth creation in the market. Welcure Drugs & Pharmaceuticals and Concord Control Systems are two stocks that investors should keep a careful eye on because they are scheduled to trade ex-bonus this week, ahead of Diwali.

With the announcement of Concord Control Systems' generous 3:5 bonus share issue, eligible shareholders will get three new shares for every five they currently own. Welcure Drugs & Pharmaceuticals is scheduled to go ex-bonus in a 1:10 ratio and split its stock 1:10 at the same time. October 16 has been set as the record date for these actions by both corporations.

The crucial question remains: Is now the 'Right Time to Buy' to capture these corporate rewards and align with the spirit of the festive season?

Concord Control Systems

• Bonus Issue: 3:5
• Record date: 16th October
• Ex-bonus: 16th October

Concord Control Systems Target Price

"Concord continues to trade in a rising structure after strong gains. The stock is above its key moving averages, indicating bullish bias. Momentum appears intact. A sustained move above ₹2,850-2,900 may open higher targets. Key support lies around ₹2,600-2,650," commented Riyank Arora, technical analyst at Mehta Equities Ltd.

Welcure Drugs & Pharmaceuticals

• Bonus Issue: 1:10
• Record date: 16th October
• Ex-bonus: 16th October

Welcure Drugs Target Price

"Welcure is volatile and extended after recent run-ups. A daily close above resistance near ₹7.96 could validate a push toward higher levels (₹10+). But given prior weakness, the risk of pullback remains high. Watch support near ₹6.50-₹7.00 and manage position sizes carefully," commented Riyank Arora.

Disclaimer

The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred to as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.